Teoxane Laboratories
Delphine Nuzzo (Gaulin) has extensive work experience in the pharmaceutical and medical device industry. Delphine currently works as the Head of Product and Analytical Development at Teoxane Laboratories, where they are responsible for the design and development of Class III injectable medical devices.
Prior to their current role, they worked at GSK as the AS&T Laboratory Manager and Senior AS&T Scientist Global Support, providing expert knowledge and supervising laboratory operations for new methods development, validation, and troubleshooting. Delphine also served as the Head of Development and Technical Transfer, Director at the Competence Center of Merz Pharma - Anteis S.A.
In their earlier career, Delphine held positions at Anteis SA (Merz Pharmaceuticals) as the Head of Development (R&D) and R&D Analytical Manager, where they were responsible for new product development, process optimization, and scientific activities related to product safety and effectiveness. Delphine also worked at Cémax - CRO Clinical Services & Analytical Support as the Analytical Services and Lab Manager and Analytical Engineer, overseeing analytical laboratory operations, method development and validation, and support for clinical trials.
Delphine began their career as an Analytical Scientist at 3M Santé. Overall, they have a wealth of experience in product development, analytical science, and laboratory management.
Delphine NUZZO (GAULIN) earned their degree in Chemical Engineering from the Institut national des Sciences appliquées de Rouen, specializing in fine chemistry and chemical engineering. Delphine completed their studies at the institution between 1993 and 1998.
This person is not in any teams
Teoxane Laboratories
1 followers
When Madame Valérie Taupin created TEOXANE Laboratories in Geneva in 2003, her vision was crystal clear: to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. Today our focus remains unchanged. We are dedicated to designing and manufacturing hyaluronic acid dermal fillers and skincare products, applying industry-leading expertise and high-quality standards. Building on a firm commitment to innovation and patient satisfaction, we have strengthened our presence. In 2023, TEOXANE has over 10 subsidiaries and is present in more than 95 countries worldwide. TEOXANE is now confirmed as a major player in aesthetic medicine and skincare, offering effective solutions to practitioners worldwide, helping women and men who want to look and feel their best at all times and help them maintain their beauty in the future. Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.